Literature DB >> 9635993

The questionable role of saturated and polyunsaturated fatty acids in cardiovascular disease.

U Ravnskov1.   

Abstract

A fat diet, rich in saturated fatty acids (SFA) and low in polyunsaturated fatty acids (PUFA), is said to be an important cause of atherosclerosis and cardiovascular diseases (CVD). The evidence for this hypothesis was sought by reviewing studies of the direct link between dietary fats and atherosclerotic vascular disease in human beings. The review included ecological, dynamic population, cross-sectional, cohort, and case-control studies, as well as controlled, randomized trials of the effect of fat reduction alone. The positive ecological correlations between national intakes of total fat (TF) and SFA and cardiovascular mortality found in earlier studies were absent or negative in the larger, more recent studies. Secular trends of national fat consumption and mortality from coronary heart disease (CHD) in 18-35 countries (four studies) during different time periods diverged from each other as often as they coincided. In cross-sectional studies of CHD and atherosclerosis, one group of studies (Bantu people vs. Caucasians) were supportive; six groups of studies (West Indians vs. Americans, Japanese, and Japanese migrants vs. Americans, Yemenite Jews vs. Yemenite migrants; Seminole and Pima Indians vs. Americans, Seven Countries) gave partly supportive, partly contradictive results; in seven groups of studies (Navajo Indians vs. Americans; pure vegetarians vs. lacto-ovo-vegetarians and non-vegetarians, Masai people vs. Americans, Asiatic Indians vs. non-Indians, north vs. south Indians, Indian migrants vs. British residents, Geographic Study of Atherosclerosis) the findings were contradictory. Among 21 cohort studies of CHD including 28 cohorts, CHD patients had eaten significantly more SFA in three cohorts and significantly less in one cohort than had CHD-free individuals; in 22 cohorts no significant difference was noted. In three cohorts, CHD patients had eaten significantly more PUFA, in 24 cohorts no significant difference was noted. In three of four cohort studies of atherosclerosis, the vascular changes were unassociated with SFA or PUFA; in one study they were inversely related to TF. No significant differences in fat intake were noted in six case-control studies of CVD patients and CVD-free controls; and neither total or CHD mortality were lowered in a meta-analysis of nine controlled, randomized dietary trials with substantial reductions of dietary fats, in six trials combined with addition of PUFA. The harmful effect of dietary SFA and the protective effect of dietary PUFA on atherosclerosis and CVD are questioned.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9635993     DOI: 10.1016/s0895-4356(98)00018-3

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  27 in total

1.  Why heart disease mortality is low in France. Miscoding may explain Japan's low mortality from coronary heart disease.

Authors:  A Sekikawa; L H Kuller
Journal:  BMJ       Date:  1999-07-24

2.  VAT and fat. Will sales tax influence consumption?

Authors:  A O'Rourke
Journal:  BMJ       Date:  2000-05-27

3.  Diet-heart disease hypothesis is wishful thinking.

Authors:  Uffe Ravnskov
Journal:  BMJ       Date:  2002-01-26

4.  Short chain saturated fatty acids decrease circulating cholesterol and increase tissue PUFA content in the rat.

Authors:  Philippe Legrand; Erwan Beauchamp; Daniel Catheline; Frédérique Pédrono; Vincent Rioux
Journal:  Lipids       Date:  2010-10-06       Impact factor: 1.880

5.  Dietary fat intake and risk of stroke: allegations about dietary fat are unfounded.

Authors:  Uffe Ravnskov
Journal:  BMJ       Date:  2003-12-06

6.  Europe in transition: dietary fat is not the villain.

Authors:  Uffe Ravnskov
Journal:  BMJ       Date:  2005-10-15

7.  Fatty acid composition of habitual omnivore and vegetarian diets.

Authors:  Neil Mann; Yvonne Pirotta; Stella O'Connell; Duo Li; Fiona Kelly; Andy Sinclair
Journal:  Lipids       Date:  2006-07       Impact factor: 1.880

8.  The problematic of decision-sharing: deconstructing 'cholesterol' in a clinical encounter.

Authors:  Richard Gwyn; Glyn Elwyn; Adrian Edwards; Annabelle Mooney
Journal:  Health Expect       Date:  2003-09       Impact factor: 3.377

9.  Study of molecular mechanism of Prostaglandin E1 in inhibiting coronary heart disease.

Authors:  H J Liu; J W Ma; Z Y Qiao; B Xu
Journal:  Mol Biol Rep       Date:  2013-10-22       Impact factor: 2.316

Review 10.  Omega-6 fatty acids and coronary artery disease: the pros and cons.

Authors:  Gal Dubnov; Elliot M Berry
Journal:  Curr Atheroscler Rep       Date:  2004-11       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.